Abstract Body

Retroviruses must replicate their genomes in the presence of cytosolic DNA sensors capable of triggering an antiviral response. Here we demonstrate that HIV-1 reverse transcribed DNA products are shielded from cytosolic DNA sensors by the HIV-1 core. Treatment of HIV-1 infected cells with the capsid-binding drug PF-3450074 releases DNA products into the cytosol where they can stimulate the cGAS-STING pathway and produce a type I IFN response. HIV-1 coordinates reverse transcription and uncoating to minimize exposure of DNA products, and perturbation of either process can influence the ability of HIV-1 to induce a type I IFN response. Both wild-type and capsid-mutant HIV-1 isolates stimulate an antiviral response in macrophages that is dependent on viral DNA synthesis and impedes subsequent rounds of virus infection. Collectively, these results illustrate the interdependence of reverse transcription and uncoating, and the importance of coordinating these two viral activities to avoid immune stimulation.